IONS vs SPIR · rev $226.6M vs rev $110.5M
Ionis Pharmaceuticals Inc (IONS) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
IONS currently screens at market cap $12.28B. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the IONS and SPIR stock pages for the full models.
Not investment advice.